Assessment

53-year-old male with poorly controlled type 2 diabetes mellitus (diagnosed 6 years ago) presenting for initial endocrinology consultation due to worsening glycemic control. Patient reports classic hyperglycemia symptoms including polydipsia, polyuria (especially nocturia), intermittent blurred vision, and fatigue over the past 4-5 months. Last A1c 9.4% (increased from 8% one year ago). Self-monitored fasting glucose 170-220 mg/dL, postprandial values exceeding 250 mg/dL. Currently on metformin and glipizide with suboptimal adherence (missing several doses weekly due to work schedule and travel). Patient reports symptoms consistent with peripheral neuropathy (bilateral foot tingling, burning pain, and numbness, worse at night) and possible hypoglycemic episode (recorded glucose 62 mg/dL with associated shakiness and diaphoresis). Infrequent self-monitoring of blood glucose (1-2 times weekly).

Comorbidities include hypertension (BP today 146/88), hyperlipidemia, and possible non-alcoholic fatty liver disease (elevated liver enzymes per PCP). Strong family history of diabetes and premature cardiovascular disease (father died of MI in early 60s with diabetes; brother with diabetes). Patient has gained 20 pounds over past 3 years (current weight 238 lbs, height 5'10"). Significant snoring with witnessed apneas and non-restorative sleep concerning for obstructive sleep apnea. Sedentary lifestyle with poor dietary habits including regular soda consumption and frequent high-glycemic meals. Former smoker (20 pack-year history, quit 5 years ago). Last comprehensive eye exam 3 years ago.

Physical exam notable for elevated blood pressure 146/88, heart rate 82. Foot exam reveals reduced monofilament sensation in at least one area, intact vibration sense, and palpable pedal pulses bilaterally. No thyromegaly, no active foot ulcers.

Patient has not previously worked with diabetes educator or nutritionist. Expressed motivation to improve glycemic control, lose weight, and prevent complications. Open to technology including continuous glucose monitoring.

Plan

1. Diabetes management: Intensify treatment regimen given A1c 9.4% and symptomatic hyperglycemia. Will order comprehensive metabolic panel, A1c, lipid panel, TSH, and urine albumin-to-creatinine ratio. Consider initiating basal insulin or GLP-1 receptor agonist in addition to current oral medications. Continue metformin and reassess glipizide given hypoglycemic episode. Prescribe continuous glucose monitor to improve glucose awareness and medication adherence. Increase self-monitoring frequency.

2. Diabetic peripheral neuropathy: Symptoms of bilateral lower extremity neuropathy with reduced sensation on monofilament testing. Will initiate pharmacologic therapy for neuropathic pain. Patient counseled on importance of daily foot inspection and proper footwear.

3. Diabetic eye disease screening: No eye exam in 3 years with recent blurred vision. Refer to ophthalmology for dilated retinal examination to evaluate for diabetic retinopathy.

4. Nephropathy screening: Order urine albumin-to-creatinine ratio and serum creatinine with eGFR to assess for diabetic kidney disease.

5. Hypertension: Blood pressure elevated today at 146/88. Continue lisinopril. Will reassess after labs and consider dose adjustment.

6. Obstructive sleep apnea: Loud snoring, witnessed apneas, non-restorative sleep, and obesity concerning for OSA. Refer for sleep study.

7. Cardiovascular risk: Strong family history of premature CAD, diabetes, hypertension, hyperlipidemia, former smoker. Continue atorvastatin. Will review lipid panel results.

8. Lifestyle modification: Refer to certified diabetes educator and registered dietitian for medical nutrition therapy, carbohydrate counting, and diabetes self-management education. Encourage gradual increase in physical activity with goal of 150 minutes weekly. Eliminate regular soda and reduce high-glycemic foods. Weight loss goal of 5-10%.

9. Follow-up: Return to endocrinology clinic in 4-6 weeks to review laboratory results, assess response to treatment intensification, and adjust medications as needed. Patient verbalized understanding and agreement with plan.